Adrenal carcinoma is an extremely rare cause of primary hyperaldosteronism.

Measuring aldosterone alone is not considered adequate to diagnose primary hyperaldosteronism.

It is a cause of primary hyperaldosteronism.

A high aldosterone-to-renin ratio indicates presence of primary hyperaldosteronism.

Conn's syndrome is primary hyperaldosteronism caused by an aldosterone-producing adenoma.

The aldosterone/renin ratio is recommended as screening tool for primary hyperaldosteronism.

After extensive research he had found a condition he called primary hyperaldosteronism, later called Conn syndrome.

The cutoff normal individuals from those with primary hyperaldosteronism is significantly affected by the conditions of testing, such as posture and time of day.

Primary hyperaldosteronism are conditions in which the adrenal gland releases too much of the hormone aldosterone.

An ARR value in an individual that is higher than the cutoff indicates primary hyperaldosteronism.

Primary hyperaldosteronism has many causes, including adrenal hyperplasia and adrenal carcinoma.

Primary hyperaldosteronism used to be considered a rare condition, but some experts believe that it may be the cause of high blood pressure in some patients.

Most cases of primary hyperaldosteronism are caused by a noncancerous tumor of the adrenal gland.

Both renin and aldosterone are measured, and a ratio greater than 30 is indicative of primary hyperaldosteronism.

If a patient is thought to suffer from primary hyperaldosteronism, the aldosterone:renin activity ratio is used to assess this.

Primary hyperaldosteronism (Conn syndrome).

If the inverse ratio (i.e. renin-to-angiotensin) ratio is used, a value lower than the cutoff indicates primary hyperaldosteronism.

Escape from the sodium-retaining effects of excess aldosterone (or other mineralocorticoids) in primary hyperaldosteronism, manifested by volume and/or pressure natriuresis.

Primary hyperaldosteronism (also known as Conn's syndrome), is due to an aldosterone-secreting adrenal tumor (adenoma) or adrenal hyperplasia.

When taking a blood test, the aldosterone-to-renin ratio is abnormally increased in primary hyperaldosteronism, and decreased or normal but with high renin in secondary hyperaldosteronism.

These include renal artery stenosis and tumors (generally non-malignant) of the adrenal glands, e.g., Conn's syndrome (primary hyperaldosteronism).

Primary aldosteronism, also known as primary hyperaldosteronism, is characterized by the overproduction of aldosterone by the adrenal glands, when not a result of excessive renin secretion.

Aldosteronism, Primary Hyperaldosteronism, Primary None Conn Syndrome is characterized by an increased level of the hormone aldosterone in the blood causing increased sodium levels in the blood.

Spironolactone is used primarily to treat heart failure, ascites in patients with liver disease, low-renin hypertension, hypokalemia, secondary hyperaldosteronism (such as occurs with hepatic cirrhosis), and Conn's syndrome (primary hyperaldosteronism).

Elevated renin due to renal artery stenosis or a very rare renin-producing juxtaglomerular cell tumor of the kidney can produce secondary hyperaldosteronism (as apposed to primary hyperaldosteronism aka Conn syndrome, usually due to a functional adrenal adenoma).